Heron Therapeutics, Inc. (HRTX)
0.3181
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
0.3181
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Debt to Equity Ratio : 21.48 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.48 |
| March 31, 2026 | 15.50 |
| December 31, 2025 | 9.812 |
| September 30, 2025 | 9.435 |
| June 30, 2025 | -6.484 |
| March 31, 2025 | -6.230 |
| December 31, 2024 | -5.282 |
| September 30, 2024 | -4.456 |
| June 30, 2024 | -4.710 |
| March 31, 2024 | -5.306 |
| December 31, 2023 | -5.287 |
| September 30, 2023 | -6.478 |
| June 30, 2023 | -3.974 |
| March 31, 2023 | -13.73 |
| December 31, 2022 | 11.60 |
| September 30, 2022 | 7.038 |
| June 30, 2022 | -7.293 |
| March 31, 2022 | 6.637 |
| December 31, 2021 | 2.056 |
| September 30, 2021 | 1.384 |
| June 30, 2021 | 1.032 |
| March 31, 2021 | 0.1245 |
| December 31, 2020 | 0.1041 |
| September 30, 2020 | 0.0897 |
| June 30, 2020 | 0.0775 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0695 |
| December 31, 2019 | 0.049 |
| September 30, 2019 | 0.0626 |
| June 30, 2019 | 0.0591 |
| March 31, 2019 | 0.056 |
| December 31, 2018 | 0.0124 |
| September 30, 2018 | 0.0107 |
| June 30, 2018 | 0.0674 |
| March 31, 2018 | 0.3134 |
| December 31, 2017 | 0.2187 |
| September 30, 2017 | 0.7111 |
| June 30, 2017 | 0.4095 |
| March 31, 2017 | 0.5197 |
| December 31, 2016 | -2.490 |
| September 30, 2016 | 2.949 |
| June 30, 2016 | 0.0442 |
| March 31, 2016 | 0.0258 |
| December 31, 2015 | 0.0188 |
| September 30, 2015 | 0.0145 |
| June 30, 2015 | 0.0119 |
| March 31, 2015 | 0.0364 |
| December 31, 2014 | 0.0253 |
| September 30, 2014 | 0.0179 |
| June 30, 2014 | 0.0133 |
| March 31, 2014 | 0.021 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Praxis Precision Medicines, Inc. | 0.0008 |
| Tonix Pharmaceuticals Holding Corp. | 0.0057 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 252.26M |
| Total Liabilities (Quarterly) | 245.35M |
| Shareholders Equity (Quarterly) | 6.908M |
| Current Ratio | 2.494 |
| Net Debt Paydown Yield | 7.15% |